UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 292

Sortiert nach

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Annals of oncology, 2007-09, Vol.18 (9), p.1529-1538

2007

Volltextzugriff (PDF)

Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand

Anti-cancer agents in medicinal chemistry, 2018-01, Vol.18 (11), p.1508

2018

Volltextzugriff (PDF)

Radiosensitization of cervical cancer cells with epigenetic drugs hydralazine and valproate

European journal of gynaecological oncology, 2014, Vol.35 (2), p.140-142

2014

Volltextzugriff (PDF)

Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure

Journal of clinical pharmacy and therapeutics, 2014-08, Vol.39 (4), p.368-375

2014

Volltextzugriff (PDF)

Pharmacogenetics and pharmacoepigenetics of gemcitabine

Medical oncology (Northwood, London, England), 2010-12, Vol.27 (4), p.1133-1143

2010

Volltextzugriff (PDF)

The prognostic significance of leukocytosis in cervical cancer

International journal of gynecological cancer, 2007-03, Vol.17 (2), p.465-470

2007

Volltextzugriff (PDF)

Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]

OncoTargets and therapy, 2022-08, Vol.15, p.845-846

2022

Volltextzugriff (PDF)

Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck

Annals of oncology, 2004-02, Vol.15 (2), p.301-306

2004

Volltextzugriff (PDF)

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients

European journal of gynaecological oncology, 2009, Vol.30 (5), p.527-530

2009

Volltextzugriff (PDF)

Características ultrasonográficas, histopatológicas y genéticas del melanoma uveal en población mexicana mestiza

Archivos de la Sociedad Española de Oftalmología, 2018-01, Vol.93 (1), p.15-21

2018

Volltextzugriff (PDF)

Ultrasound, histopathological, and genetic features of uveal melanoma in a Mexican-Mestizo population

Archivos de la Sociedad Española de Oftalmología (English ed.), 2018-01, Vol.93 (1), p.15-21

2018

Volltextzugriff (PDF)

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

Annals of oncology, 2003-08, Vol.14 (8), p.1278-1284

2003

Volltextzugriff (PDF)

Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial

Gynecologic oncology, 2012-09, Vol.126 (3), p.334-340

2012

Volltextzugriff (PDF)

Correlation of tumor growth index with early treatment response in cervical carcinoma

Journal of experimental & clinical cancer research, 2002-03, Vol.21 (1), p.57-63

2002

Volltextzugriff (PDF)

Adjuvant high‐dose chemotherapy supported by peripheral blood stem cell transplantation for high‐risk cervical carcinoma

International journal of gynecological cancer, 1999-07, Vol.9 (4), p.333-336

1999

Volltextzugriff (PDF)

Membrane proteins in neoplasic and normal uterine cervix

Journal of experimental & clinical cancer research, 2001-06, Vol.20 (2), p.231-237

2001

Volltextzugriff (PDF)

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

OncoTargets and therapy, 2018-01, Vol.11, p.8823-8833

2018

Volltextzugriff (PDF)

G3 A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix

European journal of cancer supplements, 2009, Vol.7 (3), p.7-7

2009

Volltextzugriff (PDF)

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

Annals of oncology, 2001-04, Vol.12 (4), p.541-547

2001

Volltextzugriff (PDF)

The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer

Molecular biology reports, 2024-12, Vol.51 (1), p.174-174, Article 174

2024

Volltextzugriff (PDF)

Type III radical hysterectomy induction chemotherapy for patients with locally advanced cervical carcinoma: Response

International journal of gynecological cancer, 2002-03, Vol.12 (2), p.232-233

2002

Volltextzugriff (PDF)

Hereditary diffuse gastric cancer (HDGC). An overview

Clinics and research in hepatology and gastroenterology, 2022-04, Vol.46 (4), p.101820-101820, Article 101820

2022

Volltextzugriff (PDF)

Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin

Oncology reports, 2015-02, Vol.33 (2), p.721-728

2015

Volltextzugriff (PDF)

Management of cervical cancer in low-resource settings

Gynecologic oncology, 2012-03, Vol.125, p.S51-S52

2012

Volltextzugriff (PDF)

Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate

International journal of oncology, 2011-12, Vol.39 (6), p.1491-1499

2011

Volltextzugriff (PDF)

1 – 25 von 292

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(254)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(160)
Humans
(133)
Oncology
(99)
Female
(95)
Adult
(59)
Middle Aged
(59)
Aged
(43)
Cervical Cancer
(38)
Pharmacology & Pharmacy
(36)
Uterine Cervical Neoplasms - Drug Therapy
(33)
Cancer
(30)
Uterine Cervical Neoplasms - Pathology
(30)
Biological And Medical Sciences
(29)
Medical Sciences
(27)
Male
(26)
Neoplasm Staging
(26)
Antineoplastic Agents - Therapeutic Use
(25)
Treatment Outcome
(24)
Animals
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand

Radiosensitization of cervical cancer cells with epigenetic drugs hydralazine and valproate

Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure

Pharmacogenetics and pharmacoepigenetics of gemcitabine

The prognostic significance of leukocytosis in cervical cancer

Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]

Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients

Características ultrasonográficas, histopatológicas y genéticas del melanoma uveal en población mexicana mestiza

Ultrasound, histopathological, and genetic features of uveal melanoma in a Mexican-Mestizo population

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial

Correlation of tumor growth index with early treatment response in cervical carcinoma

Adjuvant high‐dose chemotherapy supported by peripheral blood stem cell transplantation for high‐risk cervical carcinoma

Membrane proteins in neoplasic and normal uterine cervix

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

G3 A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer

Type III radical hysterectomy induction chemotherapy for patients with locally advanced cervical carcinoma: Response

Hereditary diffuse gastric cancer (HDGC). An overview

Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin

Management of cervical cancer in low-resource settings

Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate

Suchergebnisse filtern